| 2024/05/31 22:26:46 | |
|---|---|
| Price | |
| 2.485 EUR | |
| Difference | 26.53% (0.52) |
General attributes
| ISIN | NL00150002Q7 |
| Symbol | VVY |
| Exchange | Tradegate |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 62 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | 2.47 EUR (300) |
| Ask (Ask size) | 2.50 EUR (4,705) |
| Open | 1.90 EUR |
| High | 2.85 EUR |
| Low | 1.862 EUR |
| Close (prev. day) | 1.964 EUR |
| VWAP | 2.38759 EUR |
| Volume (pcs) | 683,027 |
| Trading volume | 1,630,786.57 |
| Number of trades | 440 |
| Last size | - |
Futures and Options
| Related Futures | - |
| Related Options | - |
PDF Downloads
| Company report: VIVORYON THERAPEUTICS AG |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2024/05/29 |
|
Global Equity Ratings |
|
| 2024/04/26 |
|
Global Equity Ratings |
|
| 2024/04/03 |
|
Global Equity Ratings |
|
| 2024/03/13 |
|
Global Equity Ratings |
|
| 2024/02/22 |
|
Global Equity Ratings |
|
| 2024/05/31 22:26:46 | |
|---|---|
| Price | |
| 2.485 EUR | |
| Difference | 26.53% (0.52) |
General attributes
| ISIN | NL00150002Q7 |
| Symbol | VVY |
| Exchange | Tradegate |
| Currency | EUR |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 62 EUR |
| Benchmark | GERMANY DAX |
Market data
| Bid (Bid size) | 2.47 EUR (300) |
| Ask (Ask size) | 2.50 EUR (4,705) |
| Open | 1.90 EUR |
| High | 2.85 EUR |
| Low | 1.862 EUR |
| Close (prev. day) | 1.964 EUR |
| VWAP | 2.38759 EUR |
| Volume (pcs) | 683,027 |
| Trading volume | 1,630,786.57 |
| Number of trades | 440 |
| Last size | - |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -67.62% | -82.99% | -81.62% |
| Perf (abs.) | -5.22 | -12.20 | -11.10 |
| Beta | 4.40 | 2.62 | 1.31 |
| Volatility | 401.49 | 282.68 | 171.03 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 2.859 EUR (814,497) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 1.175 EUR (217,428) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 3.839 EUR (183,044) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 7.890 EUR (75,593) |
| YTD High | date | 9.990 EUR (2024/02/19) |
| YTD Low | date | 0.421 EUR (2024/04/17) |
| 52 Weeks High | date | 14.760 EUR (2023/06/15) |
| 52 Weeks Low | date | 0.421 EUR (2024/04/17) |
All listings for VIVORYON THERAPEUTICS AG
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2024/05/31 | 22:26 | 2.485 EUR | 1.63 | 440 |
| Stuttgart | 2024/05/31 | 19:51 | 2.44 EUR | 0.03 | 19 |
| Munich | 2024/05/31 | 20:38 | 2.42 EUR | 0.01 | 4 |
| London Stock Exchange | 2024/02/02 | 16:10 | 8.313 EUR | 0.02 | 1 |
| Frankfurt | 2024/05/31 | 20:27 | 2.45 EUR | 0.04 | 22 |
| Euronext Amsterdam | 2024/05/31 | 17:38 | 2.395 EUR | 8.07 | 3,188 |
| Duesseldorf | 2024/05/31 | 08:11 | 1.858 EUR | 0.00 | 3 |
| Berlin | 2024/05/31 | 21:50 | 2.50 EUR | 0.00 | 13 |
Company Logo
Contact Details
| VIVORYON THERAPEUTICS NV |
| - - |
| Weinbergweg 22 - 06120 Halle |
| Telefon: +49-345-555-99-00 |
| Fax: + |
| E-mail: info@vivoryon.com |
PDF Downloads
| Company report: VIVORYON THERAPEUTICS AG | |
Company Profile
Vivoryon Therapeutics NV is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its product pipeline includes PQ912, PBD-C06, and PQ1565. The company was founded by Hans-Ulrich Demuth and Konrad Glund on July 25, 1997 and is headquartered in Halle, Germany. |
Members of Management Board
| Frank Weber | Chairman of Managing Board |
| Michael Schaeffer | Member of Executive Committee |
| Anne Doering | Member of Executive Committee |
| Florian Schmid | Member of Executive Committee |
Board of directors
| Erich Maximilian Platzer | Chairman of Supervisory Board |
| Claudia Riedl | Member of Supervisory Board |
| Michael Schaeffer | Member of Supervisory Board |
| Samir Shah | Member of Supervisory Board |
| Anne Doering | Member of Supervisory Board |
| Charlotte Lohmann | Member of Supervisory Board |